Moore JP - Search Results

1

Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins.

Binley JM, Sanders RW, Master A, Cayanan CS, Wiley CL, Schiffner L, Travis B, Kuhmann S, Burton DR, Hu SL, Olson WC, Moore JP. Binley JM, et al. Among authors: moore jp. J Virol. 2002 Mar;76(6):2606-16. doi: 10.1128/jvi.76.6.2606-2616.2002. J Virol. 2002. PMID: 11861826 Free PMC article.

2

CPF-DD is an inhibitor of infection by human immunodeficiency virus and other enveloped viruses in vitro.

Moore JP, Simpson G, McKeating JA, Burakoff SJ, Schreiber SL, Weiss RA. Moore JP, et al. Virology. 1992 Jun;188(2):537-44. doi: 10.1016/0042-6822(92)90508-m. Virology. 1992. PMID: 1316672

3

A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells.

Moore JP, Sattentau QJ, Klasse PJ, Burkly LC. Moore JP, et al. J Virol. 1992 Aug;66(8):4784-93. doi: 10.1128/JVI.66.8.4784-4793.1992. J Virol. 1992. PMID: 1378510 Free PMC article.

4

Complementation of human immunodeficiency virus glycoprotein mutations in trans.

Morikawa Y, Moore JP, Fenouillet E, Jones IM. Morikawa Y, et al. Among authors: moore jp. J Gen Virol. 1992 Aug;73 ( Pt 8):1907-13. doi: 10.1099/0022-1317-73-8-1907. J Gen Virol. 1992. PMID: 1645136

5

Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in vitro.

Cordell J, Moore JP, Dean CJ, Klasse PJ, Weiss RA, McKeating JA. Cordell J, et al. Among authors: moore jp. Virology. 1991 Nov;185(1):72-9. doi: 10.1016/0042-6822(91)90755-z. Virology. 1991. PMID: 1718090

6

Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization.

McKeating JA, McKnight A, Moore JP. McKeating JA, et al. Among authors: moore jp. J Virol. 1991 Feb;65(2):852-60. doi: 10.1128/JVI.65.2.852-860.1991. J Virol. 1991. PMID: 1898972 Free PMC article.

7

Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.

Moore JP, McKeating JA, Norton WA, Sattentau QJ. Moore JP, et al. J Virol. 1991 Mar;65(3):1133-40. doi: 10.1128/JVI.65.3.1133-1140.1991. J Virol. 1991. PMID: 1995942 Free PMC article.

8

Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.

Moore JP, Sattentau QJ, Wyatt R, Sodroski J. Moore JP, et al. J Virol. 1994 Jan;68(1):469-84. doi: 10.1128/JVI.68.1.469-484.1994. J Virol. 1994. PMID: 7504741 Free PMC article.

9

Characterization of mutants of human immunodeficiency virus type 1 that have escaped neutralization by a monoclonal antibody to the gp120 V2 loop.

Yoshiyama H, Mo H, Moore JP, Ho DD. Yoshiyama H, et al. Among authors: moore jp. J Virol. 1994 Feb;68(2):974-8. doi: 10.1128/JVI.68.2.974-978.1994. J Virol. 1994. PMID: 7507188 Free PMC article.

10

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.

Roben P, Moore JP, Thali M, Sodroski J, Barbas CF 3rd, Burton DR. Roben P, et al. Among authors: moore jp. J Virol. 1994 Aug;68(8):4821-8. doi: 10.1128/JVI.68.8.4821-4828.1994. J Virol. 1994. PMID: 7518527 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

769 results

Search Page

Filters